JP2022543060A5 - - Google Patents
Info
- Publication number
- JP2022543060A5 JP2022543060A5 JP2022506472A JP2022506472A JP2022543060A5 JP 2022543060 A5 JP2022543060 A5 JP 2022543060A5 JP 2022506472 A JP2022506472 A JP 2022506472A JP 2022506472 A JP2022506472 A JP 2022506472A JP 2022543060 A5 JP2022543060 A5 JP 2022543060A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- amino acid
- mage
- acid sequence
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880508P | 2019-07-30 | 2019-07-30 | |
| US62/880,508 | 2019-07-30 | ||
| PCT/IB2020/057177 WO2021019477A1 (en) | 2019-07-30 | 2020-07-29 | T cell receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543060A JP2022543060A (ja) | 2022-10-07 |
| JP2022543060A5 true JP2022543060A5 (cg-RX-API-DMAC7.html) | 2023-08-08 |
| JP7669347B2 JP7669347B2 (ja) | 2025-04-28 |
Family
ID=74229599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506472A Active JP7669347B2 (ja) | 2019-07-30 | 2020-07-29 | T細胞受容体及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220275046A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4004218A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7669347B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220038776A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114364806B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020322247A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022001697A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3146303A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL290228A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022001206A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI869426B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021019477A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020231693A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| WO2021019472A1 (en) | 2019-07-30 | 2021-02-04 | University Health Network | T cell receptors and methods of use thereof |
| AU2020320129A1 (en) | 2019-07-30 | 2022-03-03 | University Health Network | T cell receptors and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7157091B1 (en) * | 1999-06-18 | 2007-01-02 | Ludwig Institute For Cancer Research | MAGE-A1 peptides presented by HLA class II molecules |
| EP3031916B1 (en) * | 2007-06-11 | 2017-06-07 | Takara Bio Inc. | Method for expression of specific gene |
| WO2012054825A1 (en) * | 2010-10-22 | 2012-04-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-mage-a3 t cell receptors and related materials and methods of use |
| CA2912389C (en) * | 2013-06-10 | 2020-01-28 | The General Hospital Corporation D/B/A Massachusetts General Hospital | Methods and compositions for reducing immunosupression by tumor cells |
| JP2019521080A (ja) * | 2016-04-27 | 2019-07-25 | ユニバーシティ・ヘルス・ネットワーク | ペプチド−hla複合体およびその産生方法 |
| GB2573069A (en) * | 2016-12-16 | 2019-10-23 | Twist Bioscience Corp | Variant libraries of the immunological synapse and synthesis thereof |
| EA201991444A1 (ru) * | 2017-01-27 | 2019-12-30 | Имматикс Байотекнолоджиз Гмбх | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака яичника и других видов рака |
| WO2019046856A1 (en) * | 2017-09-04 | 2019-03-07 | Agenus Inc. | T-CELL RECEPTORS THAT BIND TO SPECIFIC PHOSPHOPEPTIDES OF MIXED LINEAR LEUKEMIA (MLL) AND METHODS OF USE THEREOF |
| CA3076337A1 (en) * | 2017-09-19 | 2019-03-28 | Massachusetts Institute Of Technology | Compositions for chimeric antigen receptor t cell therapy and uses thereof |
| WO2019222275A2 (en) * | 2018-05-14 | 2019-11-21 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using inducible fusion proteins |
| GB201814362D0 (en) * | 2018-09-04 | 2018-10-17 | Treos Bio Zrt | Composition and process for preparing vaccine |
| CA3127673A1 (en) * | 2019-01-25 | 2020-07-30 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting mutant ras |
-
2020
- 2020-07-29 MX MX2022001206A patent/MX2022001206A/es unknown
- 2020-07-29 CN CN202080064113.1A patent/CN114364806B/zh active Active
- 2020-07-29 KR KR1020227006954A patent/KR20220038776A/ko not_active Ceased
- 2020-07-29 AU AU2020322247A patent/AU2020322247A1/en active Pending
- 2020-07-29 EP EP20847664.8A patent/EP4004218A4/en active Pending
- 2020-07-29 BR BR112022001697A patent/BR112022001697A2/pt unknown
- 2020-07-29 US US17/631,830 patent/US20220275046A1/en active Pending
- 2020-07-29 CA CA3146303A patent/CA3146303A1/en active Pending
- 2020-07-29 TW TW109125670A patent/TWI869426B/zh active
- 2020-07-29 WO PCT/IB2020/057177 patent/WO2021019477A1/en not_active Ceased
- 2020-07-29 JP JP2022506472A patent/JP7669347B2/ja active Active
-
2022
- 2022-01-30 IL IL290228A patent/IL290228A/en unknown